![Marc Semigran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Semigran
Corporate Officer/Principal bei
Harvard Medical School
Profil
Marc Semigran bekleidet die Position des Senior Vice President-Medical Sciences bei MyoKardia, Inc. Zuvor hatte er die Position des medizinischen Direktors bei The General Hospital Corp. inne, war Mitglied der Abteilung für Innere Medizin bei The General Hospital Corp. und außerordentlicher Professor an der Harvard Medical School. Marc Semigran erwarb einen Bachelor-Abschluss an der Harvard University und einen Doktortitel an der Harvard Medical School.
Aktive Positionen von Marc Semigran
| Unternehmen | Position | Beginn |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2010 |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Berater | - |
Ehemalige bekannte Positionen von Marc Semigran
| Unternehmen | Position | Ende |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Corporate Officer/Principal | 22.01.2025 |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2021 |
| MYOKARDIA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2021 |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Corporate Officer/Principal | 01.11.2016 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
Ausbildung von Marc Semigran
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Health Technology |
Social Capital Suvretta Holdings Corp. III
 Social Capital Suvretta Holdings Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
